The CD28 costimulatory pathway.
Leung
H T
HT
Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, WA 98121, USA.
Linsley
P S
PS
D000069594:Abatacept; D000818:Animals; D015703:Antigens, CD; D000943:Antigens, Differentiation / Q000502:physiology*; D000951:Antigens, Neoplasm / Q000276:immunology; D018122:B7-1 Antigen / Q000502:physiology*; D018106:CD28 Antigens / Q000502:physiology*; D060908:CTLA-4 Antigen; D017635:Clonal Anergy; D006801:Humans; D018796:Immunoconjugates; D007165:Immunosuppression Therapy / Q000379:methods; D008213:Lymphocyte Activation; D051379:Mice; D015398:Signal Transduction; D013601:T-Lymphocytes / Q000502:physiology*
D015703:Antigens, CD; D000943:Antigens, Differentiation; D000951:Antigens, Neoplasm; D018122:B7-1 Antigen; D018106:CD28 Antigens; D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human; C556707:Ctla4 protein, mouse; D018796:Immunoconjugates; D000069594:Abatacept